|
|
|
Insider
Information: |
Ho Carole |
Relationship: |
Chief Medical Officer |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
143,605 |
|
Indirect Shares
|
208,219 |
|
|
Direct
Value |
$2,961,135 |
|
|
Indirect Value
|
$4,293,476 |
|
|
Total
Shares |
351,824 |
|
|
Total
Value |
$7,254,611 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
13
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
11
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
30.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-02-14 |
143,605 |
2024-02-14 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
53,720 |
162,434 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
41,120 |
138,967 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
107,316 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-10-09 |
4 |
OE |
$5.28 |
$158,400 |
I/I |
30,000 |
196,617 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-10-09 |
4 |
AS |
$40.68 |
$1,236,614 |
I/I |
(30,000) |
166,617 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-10-08 |
4 |
OE |
$5.28 |
$120,944 |
I/I |
22,906 |
189,523 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-10-08 |
4 |
AS |
$40.12 |
$918,989 |
I/I |
(22,906) |
166,617 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
110,597 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-08-29 |
4 |
AS |
$18.04 |
$315,700 |
I/I |
(17,500) |
218,390 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-09-04 |
4 |
AS |
$19.05 |
$333,375 |
I/I |
(17,500) |
200,890 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-10-01 |
4 |
AS |
$21.72 |
$380,100 |
I/I |
(17,500) |
183,390 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-11-15 |
4/A |
AS |
$18.07 |
$316,157 |
I/I |
(17,500) |
178,125 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-11-15 |
4 |
AS |
$18.07 |
$316,157 |
I/I |
(17,500) |
165,890 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-12-03 |
4 |
AS |
$18.43 |
$322,834 |
I/I |
(17,500) |
148,390 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-12-03 |
4/A |
AS |
$18.43 |
$322,834 |
I/I |
(17,500) |
178,125 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-12-03 |
4/A |
OE |
$5.28 |
$92,400 |
I/I |
17,500 |
195,625 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-06-10 |
4 |
AS |
$18.78 |
$241,943 |
I/I |
(12,883) |
90,923 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-11-15 |
4/A |
OE |
$5.28 |
$64,601 |
I/I |
12,235 |
195,625 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-07-08 |
4 |
AS |
$20.21 |
$222,825 |
I/I |
(10,989) |
79,934 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2024-01-05 |
4 |
S |
$19.43 |
$193,756 |
I/I |
(9,972) |
198,777 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-03 |
4 |
AS |
$26.29 |
$252,519 |
I/I |
(9,588) |
123,082 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-04 |
4 |
AS |
$26.24 |
$252,678 |
I/I |
(9,588) |
113,494 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-02 |
4 |
AS |
$25.29 |
$238,864 |
I/I |
(9,445) |
132,670 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-02-05 |
4 |
OE |
$5.28 |
$41,480 |
D/D |
7,856 |
7,856 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-02-05 |
4 |
AS |
$18.83 |
$147,928 |
D/D |
(7,856) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|